Detection of hepatitis C virus antibodies with new recombinant antigens : assessment in chronic liver diseases

A new serological assay to detect antibodies against hepatitis C, based on a recombinant protein (BHC10) which incorporates structural and non-structural viral antigens, was tested in 67 healthy subjects and 409 patients with various forms of liver disease. Results were compared with the current assay based on the recombinant non-structural viral antigen c100 and with the recently introduced second-generation assay, Ortho2. None of the healthy subjects was positive by any of the assays. In patients with chronic non-A, non-B hepatitis the prevalence of anti-BHC10 was 96.8%, higher than anti-c100 (83.3%, p less than 0.001) and similar to Ortho2 (94.3%). False-positive results were less frequently found when BHC10 was used. These findings show that assays incorporating structural and non-structural antigens provide higher sensitivity to detect hepatitis C virus infection and they define an almost exclusive role of hepatitis C virus in the genesis of chronic non-A, non-B hepatitis.

Medienart:

Artikel

Erscheinungsjahr:

1992

Erschienen:

1992

Enthalten in:

Zur Gesamtaufnahme - volume:15

Enthalten in:

Journal of hepatology - 15(1992), 3 vom: 15. Juli, Seite 309-13

Sprache:

Englisch

Beteiligte Personen:

Riezu-Boj, J I [VerfasserIn]
Parker, D [VerfasserIn]
Civeira, M P [VerfasserIn]
Phippard, D [VerfasserIn]
Corbishley, T P [VerfasserIn]
Camps, J [VerfasserIn]
Castilla, A [VerfasserIn]
Prieto, J [VerfasserIn]

Themen:

Antigens, Viral
DNA, Viral
Hepatitis Antibodies
Hepatitis C Antibodies
Hepatitis C Antigens
Journal Article
Recombinant Proteins
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 30.12.1992

Date Revised 17.08.2019

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM012604380